Polarization of Tumor-Associated Neutrophil (TAN) Phenotype by TGF-β: “N1” versus “N2” TAN

By Z. Fridlender, Jing Sun, Samuel Kim, V. Kapoor, G. Cheng, L. Ling, G. Worthen, S. Albelda. Cancer Cell, 2009

3,164 citations recorded by the source corpus.

Summary TGF-β blockade significantly slows tumor growth through many mechanisms, including activation of CD8+ T-cells and macrophages. Here, we show that TGF-β blockade also increases neutrophil-attracting chemokines resulting in an influx of CD11b+/Ly6G+ tumor-associated neutrophils (TAN) that are hypersegmented, more cytotoxic to tumor cells, and express higher levels of pro-inflammatory cytokines. Accordingly, following TGF-β blockade, depletion of these neutrophils significantly blunts anti-tumor effects of treatment and reduces CD8+ T-cell activation. In contrast, in control tumors, neutrophil depletion decreases tumor growth and results in more activated CD8+ T-cells intra-tumorally. Together, these data suggest that TGF-β within the tumor microenvironment induces a population of TAN with a pro-tumor phenotype. TGF-β blockade results in the recruitment and activation of TAN with an anti-tumor phenotype.

Subfields: Immunology, Oncology

View Paper: https://www.semanticscholar.org/paper/360fbf63fd939be00a40ae0f5bf0d3680f9a8c49

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Immunology

  1. A. Mantovani
  2. F. Balkwill
  3. A. Mócsai
  4. J. Massagué
  5. Jong-Sup Bae
  6. Jaehong Kim
  7. R. Weinberg
  8. E. Batlle

In Oncology

  1. R. Weinberg
  2. Zena Werb
  3. A. Mantovani
  4. D. Pattabiraman
  5. Arthur W. Lambert
  6. M. Egeblad
  7. E. Nakasone
  8. J. Massagué

Citations in the corpus